Chargement en cours...

Immunogenicity, safety and efficacy of tetravalent rhesus-human, reassortant rotavirus vaccine in Belém, Brazil.

A tetravalent rhesus-human reassortant rotavirus (RRV-TV) vaccine (4 x 10(4) plaque-forming units/dose) was evaluated for safety, immunogenicity and efficacy in a prospective, randomized, double-blind, placebo-controlled trial involving 540 Brazilian infants. Doses of vaccine or placebo were given a...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Linhares, A. C., Gabbay, Y. B., Mascarenhas, J. D., de Freitas, R. B., Oliveira, C. S., Bellesi, N., Monteiro, T. A., Lins-Lainson, Z., Ramos, F. L., Valente, S. A.
Format: Artigo
Langue:Inglês
Publié: World Health Organization 1996
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2486862/
https://ncbi.nlm.nih.gov/pubmed/9002329
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!